HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chi-Li Chung Selected Research

Pleural Effusion (Pleural Effusions)

2/2023Toll-like Receptor 2 Mediates VEGF Overexpression and Mesothelial Hyperpermeability in Tuberculous Pleural Effusion.
10/2019Thrombin Upregulates PAI-1 and Mesothelial-Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis.
3/2019Endothelin-1 Induces Mesothelial Mesenchymal Transition and Correlates with Pleural Fibrosis in Tuberculous Pleural Effusions.
1/2018Lipoteichoic acid upregulates plasminogen activator inhibitor-1 expression in parapneumonic effusions.
1/2015VEGF correlates with inflammation and fibrosis in tuberculous pleural effusion.
12/2007Repeated thoracenteses affect proinflammatory cytokines, vascular endothelial growth factor, and fibrinolytic activity in pleural transudates.
8/2005Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
4/2003Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chi-Li Chung Research Topics

Disease

9Neoplasms (Cancer)
06/2023 - 08/2005
9Fibrosis (Cirrhosis)
06/2021 - 06/2009
8Pleural Effusion (Pleural Effusions)
02/2023 - 04/2003
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2009
8Inflammation (Inflammations)
08/2018 - 04/2003
5Chronic Obstructive Pulmonary Disease (COPD)
12/2023 - 01/2015
5Neoplasm Metastasis (Metastasis)
06/2023 - 01/2018
5Lung Neoplasms (Lung Cancer)
06/2023 - 04/2012
5Pneumonia (Pneumonitis)
01/2018 - 08/2005
4Infections
11/2023 - 01/2015
4Thrombosis (Thrombus)
01/2022 - 08/2014
3Asthma (Bronchial Asthma)
05/2020 - 09/2005
3Stroke (Strokes)
01/2018 - 01/2015
2Brain Injuries (Brain Injury)
11/2023 - 01/2023
2COVID-19
06/2023 - 02/2022
2Cardiovascular Diseases (Cardiovascular Disease)
04/2023 - 08/2018
2Pulmonary Embolism
09/2022 - 01/2022
2Adenocarcinoma
01/2022 - 03/2014
2Adenocarcinoma of Lung
10/2021 - 09/2013
2Tuberculosis (Tuberculoses)
01/2015 - 08/2005
1Hyperglycemia
11/2023
1Cardio-Renal Syndrome
04/2023
1Weight Loss (Weight Reduction)
01/2023
1Obesity
09/2022
1Body Weight (Weight, Body)
02/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022
1Circulating Neoplastic Cells
11/2020
1Cough
05/2020
1Hypersensitivity (Allergy)
05/2020
1Pleural Diseases
03/2019

Drug/Important Bio-Agent (IBA)

7Plasminogen Activator Inhibitor 1IBA
06/2021 - 04/2003
5CytokinesIBA
06/2023 - 04/2003
5ErbB Receptors (EGF Receptor)IBA
10/2021 - 01/2013
5ORALIT (ORS)IBA
02/2019 - 01/2016
4Proteins (Proteins, Gene)FDA Link
11/2023 - 08/2014
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 04/2003
4FibrinIBA
01/2014 - 04/2003
3InterleukinsIBA
06/2023 - 04/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2023 - 01/2013
3Plasminogen Activators (Plasminogen Activator)IBA
06/2021 - 04/2012
3Matrix Metalloproteinases (MMPs)IBA
01/2015 - 03/2010
3Plasminogen InactivatorsIBA
01/2014 - 04/2003
2Therapeutic UsesIBA
11/2023 - 04/2023
2Neuroprotective AgentsIBA
01/2023 - 04/2018
2Antipsychotic Agents (Antipsychotics)IBA
10/2021 - 01/2019
2Penfluridol (Semap)IBA
10/2021 - 01/2019
2Histone Deacetylase InhibitorsIBA
06/2021 - 04/2012
2lipoteichoic acidIBA
06/2021 - 01/2018
22-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
10/2019 - 03/2019
2Tyrosine Kinase InhibitorsIBA
01/2018 - 01/2013
2Interleukin-8 (Interleukin 8)IBA
01/2013 - 04/2003
2Transforming Growth Factors (Transforming Growth Factor)IBA
04/2012 - 08/2005
2Tissue Plasminogen Activator (Alteplase)FDA Link
08/2005 - 04/2003
1Particulate MatterIBA
12/2023
1Insulin (Novolin)FDA Link
11/2023
1Caspase 3 (Caspase-3)IBA
11/2023
1Advanced Glycation End ProductsIBA
11/2023
1EnzymesIBA
11/2023
1Blood Glucose (Blood Sugar)IBA
11/2023
1Pyruvaldehyde (Methylglyoxal)IBA
11/2023
1Ketotifen (Ketotifene)FDA Link
11/2023
1COVID-19 VaccinesIBA
06/2023
1Interleukin-17 (Interleukin 17)IBA
06/2023
1Interleukin-17 ReceptorsIBA
06/2023
1indoleIBA
04/2023
1IndicanIBA
04/2023
1Toll-Like Receptors (Toll-Like Receptor)IBA
02/2023
1Toll-Like Receptor 2IBA
02/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1Messenger RNA (mRNA)IBA
01/2023
1navitoclaxIBA
01/2023
1glabridinIBA
09/2022
1Immunoglobulin G (IgG)IBA
02/2022
1VaccinesIBA
02/2022
1ChAdOx1 nCoV-19IBA
02/2022
13- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
01/2022
1rutecarpineIBA
01/2022
1Adenosine Diphosphate (ADP)IBA
01/2022
1PlatinumIBA
01/2022
1Doxycycline (Periostat)FDA LinkGeneric
06/2021
1CollagenIBA
06/2021
1SolutionsIBA
11/2020
1auraptenIBA
07/2020
1AerosolsIBA
05/2020
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
05/2020
1sodium bisulfide (NaHS)IBA
05/2020
1Capsaicin (Zostrix)FDA Link
05/2020
1Bleomycin (Blenoxane)FDA LinkGeneric
10/2019
1Fibronectins (Fibronectin)IBA
10/2019
1Peptide Hydrolases (Proteases)FDA Link
10/2019
1ThrombinFDA Link
10/2019
1SootIBA
10/2019
1matrigelIBA
10/2019
1Endothelin-1 (Endothelin 1)IBA
03/2019

Therapy/Procedure

9Therapeutics
04/2023 - 11/2013
2Length of Stay
02/2019 - 09/2005
2Drug Therapy (Chemotherapy)
01/2018 - 01/2015
2Pleurodesis
06/2009 - 04/2003
1Renal Dialysis (Hemodialysis)
06/2023
1Adjuvant Chemotherapy
01/2022